• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparison of the safety and tolerance of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.

作者信息

de Swart J B

机构信息

Cardiology Department, Hospital Sint Annadal, Maastricht.

出版信息

Drugs. 1987;33 Suppl 3:279-81. doi: 10.2165/00003495-198700333-00052.

DOI:10.2165/00003495-198700333-00052
PMID:3315607
Abstract
摘要

相似文献

1
Comparison of the safety and tolerance of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.急性心肌梗死中静脉注射茴香酰化纤溶酶原链激酶激活剂复合物与冠状动脉内注射链激酶的安全性及耐受性比较。
Drugs. 1987;33 Suppl 3:279-81. doi: 10.2165/00003495-198700333-00052.
2
Dose-ranging studies of anisoylated plasminogen streptokinase activator complex. Studies in healthy volunteers and in patients with acute myocardial infarction.
Drugs. 1987;33 Suppl 3:124-32. doi: 10.2165/00003495-198700333-00020.
3
Tolerance and complications in a multicenter trial of intravenous APSAC and intracoronary streptokinase in acute myocardial infarction.急性心肌梗死患者静脉注射氨甲环酸纤溶酶原激活剂复合物与冠状动脉内注射链激酶多中心试验中的耐受性和并发症
Clin Cardiol. 1990 Mar;Suppl 5:V11-4; discussion V27-32. doi: 10.1002/clc.4960131304.
4
Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: controlled comparison with intracoronary streptokinase.急性心肌梗死静脉注射茴香酰化纤溶酶原链激酶激活剂复合物（APSAC）的多中心再灌注试验：与冠状动脉内链激酶的对照比较
J Am Coll Cardiol. 1988 Jun;11(6):1153-63. doi: 10.1016/0735-1097(88)90276-8.
5
Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.急性心肌梗死中静脉注射茴香酰化纤溶酶原链激酶激活剂复合物与冠状动脉内注射链激酶的比较。
Am J Cardiol. 1988 Jul 1;62(1):25-30. doi: 10.1016/0002-9149(88)91359-8.
6
Comparison of intravenous anisoylated plasminogen streptokinase activator complex with intracoronary streptokinase in acute myocardial infarction.
Drugs. 1987;33 Suppl 3:151-3. doi: 10.2165/00003495-198700333-00025.
7
Comparative tolerance and complications in a multicentre trial of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
Drugs. 1987;33 Suppl 3:276-8. doi: 10.2165/00003495-198700333-00051.
8
Reperfusion in acute myocardial infarction. A multicentre randomised trial of early intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in the United States.急性心肌梗死再灌注治疗。美国一项关于早期冠状动脉内注射链激酶与静脉注射茴香酰化纤溶酶原链激酶激活剂复合物的多中心随机试验。
Drugs. 1987;33 Suppl 3:154-62. doi: 10.2165/00003495-198700333-00026.
9
Coronary thrombolysis during acute myocardial infarction by intravenous BRL 26921, a new anisoylated plasminogen-streptokinase activator complex.新型茴香酰化纤溶酶原-链激酶激活剂复合物BRL 26921静脉注射用于急性心肌梗死时的冠状动脉溶栓治疗。
Am J Cardiol. 1986 Sep 1;58(6):418-21. doi: 10.1016/0002-9149(86)90006-8.
10
Safety and side effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.茴香酰化纤溶酶原链激酶激活剂复合物与链激酶在急性心肌梗死患者中的安全性及副作用。IRS II研究中期报告。
Drugs. 1987;33 Suppl 3:282-5. doi: 10.2165/00003495-198700333-00053.

引用本文的文献

1
Comparison of intravenous anisoylated plasminogen streptokinase activator complex with intracoronary streptokinase in acute myocardial infarction.
Drugs. 1987;33 Suppl 3:151-3. doi: 10.2165/00003495-198700333-00025.

本文引用的文献

1
Comparison of intravenous anisoylated plasminogen streptokinase activator complex with intracoronary streptokinase in acute myocardial infarction.
Drugs. 1987;33 Suppl 3:151-3. doi: 10.2165/00003495-198700333-00025.